Jian Geng

2.4k total citations · 1 hit paper
58 papers, 1.7k citations indexed

About

Jian Geng is a scholar working on Molecular Biology, Oncology and Nephrology. According to data from OpenAlex, Jian Geng has authored 58 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Nephrology. Recurrent topics in Jian Geng's work include Chronic Kidney Disease and Diabetes (8 papers), Renal Diseases and Glomerulopathies (5 papers) and Immunotherapy and Immune Responses (4 papers). Jian Geng is often cited by papers focused on Chronic Kidney Disease and Diabetes (8 papers), Renal Diseases and Glomerulopathies (5 papers) and Immunotherapy and Immune Responses (4 papers). Jian Geng collaborates with scholars based in China and United States. Jian Geng's co-authors include Xiaoyan Bai, Zhanmei Zhou, Jianwei Tian, Jiao Wan, Guobao Wang, Xiaoyan Hou, Sheng Nie, Yang Luo, Gang Xu and Chin‐Lee Wu and has published in prestigious journals such as Nature Communications, Oncogene and Scientific Reports.

In The Last Decade

Jian Geng

54 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China

2016 338 citations Xin Xu, Guobao Wang et al. Journal of the American Society of Nephrology profile →

Peers

Countries citing papers authored by Jian Geng

Since Specialization

Citations

This map shows the geographic impact of Jian Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Geng more than expected).

Fields of papers citing papers by Jian Geng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Geng. The network helps show where Jian Geng may publish in the future.

Co-authorship network of co-authors of Jian Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Geng. A scholar is included among the top collaborators of Jian Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Geng. Jian Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Erythromycin repurposing for hepatocellular carcinoma treatment: Targeting CD24 to enhance anti-tumor immunity 2025 ·European Journal of Pharmacology ·(unknown), Tiesuo Zhao, Qian Li, Xiaolong Jia, Zhihan Chen, (unknown), Yuanli Sun, Xiaoyu Dong, Jian Geng, Yongxi Zhang, Sheng Guo, (unknown), Wei Tian, Huijie Jia	1
2	Role of ILC2s as Potential Effector Cells of IL25-Mediated Type 2 Inflammation in Chronic Rhinosinusitis with Nasal Polyps in China 2025 ·Journal of Inflammation Research ·Qiuning Yu, (unknown), (unknown), Jian Geng, Xuyang Liu, Tingting Liang, Shaochi Wang, Yulin Zhao	0
3	Renal Lipid Alterations From Diabetes to Early‐Stage Diabetic Kidney Disease and Mitophagy: Focus on Cardiolipin 2025 ·Journal of Cellular and Molecular Medicine ·Zhijie Li, Hongmiao Wang, Nan Liu, Xiabin Lan, (unknown), Yuan Ge, (unknown), Jian Geng, Xiaodan Liu	0
4	Exploring the mediating roles of stigma and perceived social support between health literacy and health care decision-making barriers among patients with cervical cancer 2025 ·Asia-Pacific Journal of Oncology Nursing ·(unknown), Jian Geng, Qīng Wáng, (unknown), (unknown)	0
5	Deformable R-CNN for Detection of Electron Dense Deposits in Glomerular Transmission Electron Microscopy Images 2024 ·IEEE Access ·Shuo Liu, (unknown), Yanmeng Lu, Jian Geng, Zhitao Zhou, (unknown)	1
6	Dynamic viral integration patterns actively participate in the progression of BK polyomavirus-associated diseases after renal transplantation 2023 ·American Journal of Transplantation ·(unknown), (unknown), Yanna Liu, (unknown), (unknown), Jian Geng, Zhuolin Li, (unknown), (unknown), Ting Zhao, Yiling Fang, (unknown), Lingling Yang, Zhongyi Cheng, Jian Xu, Chin‐Lee Wu, Yun Miao	8
7	GCLR: A self-supervised representation learning pretext task for glomerular filtration barrier segmentation in TEM images 2023 ·Artificial Intelligence in Medicine ·Guoyu Lin, (unknown), (unknown), Yiwen Zhang, (unknown), Jian Geng, Zhitao Zhou, Qianjin Feng, Lijun Lu, (unknown)	4
8	CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways 2020 ·Theranostics ·(unknown), Xiaoli Long, Shiyu Duan, Xunhua Liu, Jian‐Xiong Chen, (unknown), Xuming Liu, Wen-Qing Huang, Jian Geng, Jun Zhou	28
9	Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy 2019 ·Antioxidants and Redox Signaling ·Li Xiao, Ting Zhang, Jian Geng, (unknown), (unknown), (unknown), Jianwei Tian, Zhanmei Zhou, Jing Nie, Xiaoyan Bai	51
10	WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy 2017 ·Free Radical Biology and Medicine ·Jiao Wan, Xiaoyan Hou, Zhanmei Zhou, Jian Geng, Jianwei Tian, Xiaoyan Bai, Jing Nie	38
11	Computed Tomographic Angiography-Based Characterization of Source Blood Vessels for Nipple–Areola Complex Perfusion in Hypertrophic Breasts 2017 ·Aesthetic Plastic Surgery ·Hui Zheng, Yingjun Su, Minwen Zheng, Jian Li, (unknown), Lihong Qiu, (unknown), Jian Geng, Chenggang Yi	13
12	Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China breakdown → 2016 ·Journal of the American Society of Nephrology ·Xin Xu, Guobao Wang, Nan Chen, Tao Lu, Sheng Nie, Gang Xu, Ping Zhang, Yang Luo, Yong-Ping Wang, Xiaobin Wang, Joel Schwartz, Jian Geng, Fan Fan Hou	338
13	FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10 2016 ·Oncotarget ·Tao Xie, Jian Geng, Ye Wang, Liya Wang, Mengxi Huang, Jing Chen, (unknown), Lijun Xue, Xiang Liu, Xiaobei Mao, Yanan Chen, Qian Wang, Tingting Dai, Lili Ren, (unknown), Rui Wang, Longbang Chen, Cheng Chen, Xiaoyuan Chu	59
14	MicroRNA-130b Improves Renal Tubulointerstitial Fibrosis via Repression of Snail-Induced Epithelial-Mesenchymal Transition in Diabetic Nephropathy 2015 ·Hong Kong Journal of Nephrology ·Xiaoyan Bai, Jian Geng, Zhanmei Zhou, Jianwei Tian, Li Xiao	13
15	Recombinant Mutated Human TNF in Combination with Chemotherapy for Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Phase III Study 2015 ·Scientific Reports ·Xiaowen Ma, Yang Song, Kuo Zhang, Lei Shang, Yuan Gao, Wei Zhang, Xiaochang Xue, Huimin Jia, Jian Geng, Wei Zhou, (unknown), Enxiao Li, Xinyu Ti, (unknown), Yingqi Zhang, (unknown)	10
16	Identification of a New Cytotoxic T-Cell Epitope p675 of Human Telomerase Reverse Transcriptase 2012 ·Cancer Biotherapy and Radiopharmaceuticals ·Guichun Huang, Jian Geng, Rui Wang, Longbang Chen	3
17	Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome 2012 ·Journal of Thoracic Oncology ·Xiao Li, Liyan Wan, Jian Geng, Chin‐Lee Wu, Xiaoyan Bai	66
18	Thyroid Transcription Factor-1 Amplification and Expressions in Lung Adenocarcinoma Tissues and Pleural Effusions Predict Patient Survival and Prognosis 2011 ·Journal of Thoracic Oncology ·Xiao Li, Liyan Wan, Hong Shen, Jian Geng, Jing Nie, Guobao Wang, Nan Jia, Meng Dai, Xiaoyan Bai	29
19	Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma 2009 ·Journal of Experimental & Clinical Cancer Research ·Zhengrong Wu, Lirong Wu, Desheng Weng, Dazhi Xu, Jian Geng, Fei Zhao	89
20	XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis 2008 ·World Journal of Gastroenterology ·Jian Geng, Youwei Zhang, Guichun Huang, Longbang Chen	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact